Dr Reddy’s Laboratories has launched sumatriptan injection USP, autoinjector system 6 mg/0.5 mL, for subcutaneous use, a therapeutic equivalent generic version of Imitrex STATdose Pen (sumatriptan succinate) 6 mg/0.5 mL in the US market on February 25, 2014, following the approval by the US FDA.

The Imitrex STATdose Pen (sumatriptan succinate) brand and generic combined had US sales of approximately $169 million MAT for the most recent twelve months ending in December 2013 according to IMS Health.

Dr Reddy’s sumatriptan injection USP, autoinjector system 6 mg/ 0.5 mL is available in a carton containing 2 single-dose prefilled syringes.